Uncategorized

The demonstration of a trans-Atlantic operation using Intuitive Surgical’s da Vinci 5 robot on a tissue model was a focus at the Society of Robotic Surgery meeting in France.

Companies have improved their recovery processes and user controls but still lag in risk preparedness, according to the report.

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government to negotiate pay-for-performance deals with the manufacturers of products like Casgevy and Lyfgenia.

With venture funding tightening in the post-COVID landscape, efficiency has become more critical than ever. In this interactive webinar industry experts explored actionable strategies for maintaining quality under financial pressure. Watch now.

The money will also help the company complete enrollment in a randomized controlled trial of patients with newly diagnosed brain metastases.

Coverage losses linked to the massive tax and policy law could drive up excess deaths and preventable hospitalizations by 2034, according to the study in JAMA Health Forum.

The proposed rule would send an additional $8 billion to hospitals next year, but includes a number of other policies hospital groups have criticized.

The orthopedics firm is looking to round out its robotics offerings with the planned $177 million acquisition. Some analysts questioned the value of a fully autonomous robot.

J&J’s electrophysiology group returned to growth in the second quarter after a decline in the prior quarter. Now, can the healthcare giant catch up with its rivals in pulsed field ablation?

The antibody anselamimab, which AstraZeneca picked up in its 2021 purchase of Caelum Biosciences, failed to improve survival and reduce hospitalizations, but the company sees promise in data from an unspecified patient subgroup.